It may feel like there are a lot of goals, directions, or specialties to focus on in 2025. However, one area of the eye can often take a backseat to other priorities until damage has been done. Make … read more

EyePromise® has exciting news! A clinical evaluation of the Zx Pro™ macular pigment optical density (MPOD) measurement device was recently published in the MPDI journal: Diagnostics. The … read more

Blood sugar control issues continue to be a problem in 2025. These issues are viewed as systemic, whole-body issues, but the impact they can have on the eyes means that eye care professionals (ECPs) … read more

Blood sugar control issues are a growing problem not only in the U.S., but across the world. In fact, global numbers of blood sugar control issues are expected to increase by 46% over the next two … read more

Few ocular measurements give you a better picture into eye and overall health like macular pigment optical density (MPOD). As a risk factor for age-related eye health, blood sugar control issues, … read more